Joshua Khalili, MD, from UCLA, discusses his new paper published in JAMA Internal Medicine, which details the key role primary care practitioners play in prescribing tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) or similar agents for pre-exposure prophylaxis among uninfected populations who are at risk of acquiring HIV infection. For more, visit www.consultant360.com.